MedTrace Logo

Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis

NCT03316664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2021-09-16

No results posted yet for this study

Summary

This randomised three-arm study aims to evaluate the efficacy and feasibility of a cognitive behavioral therapy (INT-Integrated Neurocognitive Therapy for Schizophrenia Patients) in the treatment of schizophrenia patients in an inpatient setting. The intervention will be compared with an active comparator (IPT- Integrated Psychological Therapy) and a control condition. Overall the study will include 90 patients (30 in each arm). Each patient will receive at least 16 sessions of the respective treatment. Baseline and follow up assessments up to 12 months after the intervention will investigate the stability of treatment.

Conditions

Interventions

BEHAVIORAL

Integrated Neurocognitive Therapy (INT)

Information already included in arm/group description.

BEHAVIORAL

Integrated Psychological Therapy (IPT)

Information already included in arm/group description.

OTHER

COGPACK

Information already included in arm/group description.

Sponsors & Collaborators

  • Psychiatric University Hospital, Zurich

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-07-31
Completion
2021-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03316664 on ClinicalTrials.gov